Similarities, Differences, and Opportunities in MENA Markets
The Middle East and North Africa are becoming increasingly important pharmaceutical markets, leading many companies to seek support in countries in the region. Across the MENA region, the pharmaceutical market was valued at $36 billion in 2016 and in recent years has seen growth of 10 percent, well above global growth of 4 to 6 percent.
However, with countries across the Gulf states, Israel, and North Africa, there are many different regulatory requirements and expectations for companies to manage. The good news for companies is there have been increasing efforts to standardize and streamline processes, but many challenges and inconsistencies remain.